glp 1 agonists and pancreatitis Frontiers Risk of pancreatic cancer associated

Description

Despite a described effect of GLP-2 on osteoclast activity, the GLP-2 receptor has not been identified in human osteoclasts or any other bone-related cell type [69], except for immature human osteoblast cell lines MG-63 and TE-85 [69]

Read the paper: To view or add a comment, sign in

Table 1 summarizes the RCTs that measured the weight-reducing effects and the other secondary outcomes of GLP-1RA in PCOS patients

Benefits GLP-1 agonists are effective in weight loss as they delay gastric emptying, induce satiety, and decrease food These agents have been successfully studied in obese, non-diabetic patients Weight loss results seen as early as two weeks into treatment Liraglutide especially is shown to be effective for long-term (2 year) weight loss Liraglutide even produces greater weight loss results than orlistat More favorable effects on HbA1c and blood pressure seen with liraglutide vs

There are no randomised controlled trials supporting their use in this condition, and patients should continue evidence-based therapies such as disease-modifying antirheumatic drugs (DMARDs) as recommended by NICE guidance